You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Shilpa Medicare gains after board's nod to raise foreign investment limit

Capital Market 

rose 1.27% to Rs 667.65 at 10:53 on after the company's board proposed to increase the foreign investors' shareholding limit to 40% from the existing limit of 30%.

The announcement was made after market hours yesterday, 1 December 2016.

Meanwhile, the S&P Sensex was down 239.26 points or 0.9% at 26,320.66.

On the BSE, 9,843 shares were traded on the counter so far as against the average daily volumes of 11,284 shares in the past one quarter. The stock had hit a high of Rs 683.90 and a low of Rs 660.55 so far during the day.

The stock had hit a record high of Rs 686 on 28 November 2016 and a 52-week low of Rs 355 on 20 January 2016.

The mid-cap company has equity capital of Rs 7.71 crore. Face value per share is Rs 1.

Shilpa Medicare's board at its meeting held yesterday, 1 December 2016, approved raising of funds up to Rs 175 crore by issuing equity shares on preferential basis to TA FII Investors, Mauritius, at Rs 570 per share, which will be classified as a non-promoter shareholder.

On a consolidated basis, Shilpa Medicare's net profit rose 63.9% to Rs 38.24 crore on 21.1% growth in net sales to Rs 209.67 crore in Q2 September 2016 over Q2 September 2015.

is engaged in the business of bulk drugs manufacturing.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Shilpa Medicare gains after board's nod to raise foreign investment limit

Shilpa Medicare rose 1.27% to Rs 667.65 at 10:53 IST on BSE after the company's board proposed to increase the foreign investors' shareholding limit to 40% from the existing limit of 30%.

rose 1.27% to Rs 667.65 at 10:53 on after the company's board proposed to increase the foreign investors' shareholding limit to 40% from the existing limit of 30%.

The announcement was made after market hours yesterday, 1 December 2016.

Meanwhile, the S&P Sensex was down 239.26 points or 0.9% at 26,320.66.

On the BSE, 9,843 shares were traded on the counter so far as against the average daily volumes of 11,284 shares in the past one quarter. The stock had hit a high of Rs 683.90 and a low of Rs 660.55 so far during the day.

The stock had hit a record high of Rs 686 on 28 November 2016 and a 52-week low of Rs 355 on 20 January 2016.

The mid-cap company has equity capital of Rs 7.71 crore. Face value per share is Rs 1.

Shilpa Medicare's board at its meeting held yesterday, 1 December 2016, approved raising of funds up to Rs 175 crore by issuing equity shares on preferential basis to TA FII Investors, Mauritius, at Rs 570 per share, which will be classified as a non-promoter shareholder.

On a consolidated basis, Shilpa Medicare's net profit rose 63.9% to Rs 38.24 crore on 21.1% growth in net sales to Rs 209.67 crore in Q2 September 2016 over Q2 September 2015.

is engaged in the business of bulk drugs manufacturing.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Shilpa Medicare gains after board's nod to raise foreign investment limit

rose 1.27% to Rs 667.65 at 10:53 on after the company's board proposed to increase the foreign investors' shareholding limit to 40% from the existing limit of 30%.

The announcement was made after market hours yesterday, 1 December 2016.

Meanwhile, the S&P Sensex was down 239.26 points or 0.9% at 26,320.66.

On the BSE, 9,843 shares were traded on the counter so far as against the average daily volumes of 11,284 shares in the past one quarter. The stock had hit a high of Rs 683.90 and a low of Rs 660.55 so far during the day.

The stock had hit a record high of Rs 686 on 28 November 2016 and a 52-week low of Rs 355 on 20 January 2016.

The mid-cap company has equity capital of Rs 7.71 crore. Face value per share is Rs 1.

Shilpa Medicare's board at its meeting held yesterday, 1 December 2016, approved raising of funds up to Rs 175 crore by issuing equity shares on preferential basis to TA FII Investors, Mauritius, at Rs 570 per share, which will be classified as a non-promoter shareholder.

On a consolidated basis, Shilpa Medicare's net profit rose 63.9% to Rs 38.24 crore on 21.1% growth in net sales to Rs 209.67 crore in Q2 September 2016 over Q2 September 2015.

is engaged in the business of bulk drugs manufacturing.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard